GM-CSF–mediated epithelial-immune cell cross-talk orchestrates pulmonary immunity to Aspergillus fumigatus
Science Immunology · 2025
DOI: 10.1126/sciimmunol.adr0547 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Immunology, 2025. Verfasst von Kathleen A M Mills und 14 weiteren Autor:innen. Beteiligte Einrichtung: Immunology and Microbial Pathogenesis Program, Weill Cornell Graduate School of Medical Sciences, New York, NY, USA. Hauptthemen laut MEDLINE: Aspergillus fumigatus, Granulocyte-Macrophage Colony-Stimulating Factor, Epithelial Cells, Lung. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, NCI NIH HHS.
Abstract (Originalsprache)
Aspergillus fumigatus causes life-threatening mold pneumonia in immunocompromised patients, particularly in those with quantitative or qualitative defects in neutrophils. Whereas innate immune cell cross-talk licenses neutrophil antifungal activity in the lung, the role of epithelial cells in this process is unknown. Here, we find that surfactant protein C (SPC)–expressing lung epithelial cells integrate infection-induced interleukin-1 and type III interferon signaling to produce granulocyte-macrophage colony-stimulating factor (GM-CSF) preferentially at local sites of fungal infection and neutrophil influx. Using in vivo models that distinguish the role of GM-CSF during acute infection from its homeostatic function in alveolar macrophage survival and surfactant catabolism, we demonstrate that epithelial-derived GM-CSF increases the accumulation and fungicidal activity of GM-CSF–responsive neutrophils, which is essential for host survival. Our findings establish SPC + epithelial cells as a central player in regulating the quality and strength of neutrophil-dependent immunity against inhaled mold pathogens.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Immunology and Microbial Pathogenesis Program, Weill Cornell Graduate School of Medical Sciences, New York, NY, USA.
- Institute of Experimental Immunology, University of Zurich, Zurich, Switzerland.
- Center for Immunity and Inflammation, New Jersey Medical School, Rutgers-State University of New Jersey, Newark, NJ, USA.
- Molecular Cytology Core Facility, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
- Fungal Pathogenesis Section, Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
- Louis V. Gerstner Jr. Graduate School of Biomedical Sciences, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
ORCID-Profile: Kathleen A M Mills, Frederike Westermann, Vanessa Espinosa, Eric Rosiek, Jigar V Desai, Mariano A Aufiero, Yahui Guo, Fitty L Liu, Kennedy A Mitchell, Selma Tuzlak, Donatella De Feo, Michail S Lionakis, Amariliz Rivera, Burkhard Becher, Tobias M Hohl
Förderung
- NIAID NIH HHS
- NCI NIH HHS
Zitieren
APA
Mills, K. A. M., Westermann, F., Espinosa, V., Rosiek, E., Desai, J. V., Aufiero, M. A., Guo, Y., Liu, F. L., Mitchell, K. A., Tuzlak, S., De Feo, D., Lionakis, M. S., Rivera, A., Becher, B., & Hohl, T. M. (2025). GM-CSF–mediated epithelial-immune cell cross-talk orchestrates pulmonary immunity to Aspergillus fumigatus. Science Immunology. https://doi.org/10.1126/sciimmunol.adr0547
Vancouver
Mills KAM, Westermann F, Espinosa V, Rosiek E, Desai JV, Aufiero MA, et al. GM-CSF–mediated epithelial-immune cell cross-talk orchestrates pulmonary immunity to Aspergillus fumigatus. Science Immunology. 2025. doi:10.1126/sciimmunol.adr0547
BibTeX
@article{Mills2025,
author = {Mills, Kathleen A M and Westermann, Frederike and Espinosa, Vanessa and Rosiek, Eric and Desai, Jigar V and Aufiero, Mariano A and Guo, Yahui and Liu, Fitty L and Mitchell, Kennedy A and Tuzlak, Selma and De Feo, Donatella and Lionakis, Michail S and Rivera, Amariliz and Becher, Burkhard and Hohl, Tobias M},
title = {GM-CSF–mediated epithelial-immune cell cross-talk orchestrates pulmonary immunity to Aspergillus fumigatus},
journal = {Science Immunology},
year = {2025},
doi = {10.1126/sciimmunol.adr0547}
}
EUVIMED